Randomised, Double Blind, Placebo Controlled, Multicentre Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
Phase of Trial: Phase III
Latest Information Update: 14 Apr 2018
At a glance
- Drugs Givinostat (Primary)
- Indications Duchenne muscular dystrophy
- Focus Registrational; Therapeutic Use
- Sponsors Italfarmaco
- 07 Jul 2017 Status changed from not yet recruiting to recruiting.
- 21 Mar 2017 Planned initiation date changed from 1 Oct 2016 to 1 Apr 2017.
- 04 Aug 2016 New trial record